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1684-1182/Copyright ª 2015, TaiwanAbstract Background/Purpose: To investigate the clinical manifestations and bacteriological
features of culture-proven, Gram-negative bacterial arthritis.
Methods: This study was conducted at the Chi Mei Medical Center, a 1300-bed teaching hospi-
tal located in southern Taiwan. Patients with synovial fluid cultures positive for Gram-negative
bacilli (GNB) during the period January 2009 to May 2014 were identified from the hospital’s
computerized microbiology database.
Results: During the study period, a total of 48 patients with culture-confirmed, GNB septic
arthritis were identified. In the majority of patients (n Z 33, 68.8%), the knee was the most
commonly involved joint. The most common causative pathogen was Pseudomonas spp.
(n Z 16, 33.3%), followed by Escherichia coli (n Z 13, 28.1%). Among the 29 clinical isolates
of Enterobacteriaceae, eight (27.6%) were resistant to ceftriaxone and six (20.7%) were resis-
tant to cefpirome. Three E. coli isolates and three Klebsiella pneumoniae isolates were
extended-spectrum beta-lactamase producers (n Z 6, 20.7%). Among the nonfermenting
GNB (NFGNB), 21.1% were resistant to ceftazidime, 21.1% were resistant to ciprofloxacin,
26.3% were resistant to piperacillin-tazobactam, and 15.8% were resistant to imipenem. The
overall mortality rate was 10.4%, and the significant risk factors for death were concomitantt of Intensive Care Medicine, Chi Mei Medical Center, Liouying, 201, Taikang Village, Liou Ying
, ROC.
.com.tw (C.-M. Chao).
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bacterial arthritis, Journal of Microbbacteremia [odds ratio (OR): 14.6, 95% confidence interval (CI): 1.9e115.2, p Z 0.011] and
liver cirrhosis (OR: 20.0, 95% CI: 2.4e169.9, p Z 0.006).
Conclusion: Approximately 25% of cases of septic arthritis were due to GNB and resistance to
commonly used antimicrobial agents was common. Liver cirrhosis and concomitant bacteremia
were significant risk factors for death.
Copyright ª 2015, Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC. All rights
reserved.Introduction
Septic arthritis is inflammation of a joint due to bacterial,
mycobacterial, or fungal infection.1 Without appropriate
treatment, septic arthritis can lead to the irreversible
destruction and dysfunction of the joint. The reported
incidence ranges from four to 29 cases per 100,000 person-
years.2 Gram-positive bacteria are the most common
causative pathogens, with Staphylococcus aureus and
Streptococcus pneumonia being the most frequently iso-
lated.3e6 Septic arthritis is less commonly caused by Gram-
negative bacilli (GNB), accounting for only 14e19% of septic
arthritis cases.7,8
Treatment of septic arthritis requires appropriate antibi-
otics and drainage. The initial use of antibiotics should be
based on knowledge of the epidemiology of the causative
bacterium and its drug-resistance pattern; however, little is
known about the bacteriology and associated antibiotic-
resistance patterns of GNB causing septic arthritis.4,8 The
aimof this studywas to investigate the clinicalmanifestations
of patients with septic arthritis due to GNB and to evaluate
the bacteriology and antibiotic-resistant patterns of GNB.Methods
Hospital setting and patient selection
This study was conducted at the Chi Mei Medical Center, a
1300-bed hospital in southern Taiwan. All patients with
synovial fluid cultures positive for GNB during the period
from January 2009 to May 2014 were retrospectively iden-
tified from the computerized database of the microbiology
department. Information was collected on age, gender, and
underlying conditions including the history of immunosup-
pressant drug use, diabetes mellitus, liver cirrhosis, end-
stage renal disease, and malignancy. Infections were clas-
sified as health care-associated infections in patients who
acquired the disease during the course of treatment for
other conditions within a health care setting. Otherwise,
septic arthritis was classified as community acquired. Pol-
ymicrobial infections were diagnosed in patients from
whom GNB isolates in addition to other pathogens were
isolated from synovial fluid specimens. Immunocompro-
mised status was diagnosed in patients with liver cirrhosis,
diabetes mellitus, end-stage renal disease, or active can-
cer. Concomitant bacteremia was diagnosed in patients
whose blood cultures were positive for the same species
yielded from synovial fluid. In-hospital mortality wasn W-T, et al., Clinical manifestati
iology, Immunology and Infectiondefined as death from all causes during hospitalization. The
data were collected on a routine basis, and the analysis was
performed retrospectively. Therefore, no informed consent
was required, and the Institutional Review Board of the Chi
Mei Medical Center specifically waived the need for
informed consent when it approved the study.
Bacterial isolates and antimicrobial susceptibilities
All isolates were identified by conventional methods and
the susceptibilities of the isolates to a battery of antimi-
crobial agents were determined using the disk diffusion
method as described by the Clinical and Laboratory Stan-
dards Institute.
Statistical analysis
Continuous variables are expressed as means  standard
deviations and were compared using the Wilcoxon rank sum
test or Student independent t test, as appropriate. Cate-
gorical variables were compared using the Chi-square test
or Fisher’s exact test. A p value <0.05 was considered to
indicate statistical significance. All statistical analyses
were performed with the statistical package SPSS for Win-
dows (version 19.0, SPSS Inc., Chicago, IL, USA).
Results
Patient demographics and clinical characteristics
Of the 194 patients with culture-confirmed septic arthritis
identified during the study period, 48 (24.7%) had septic
arthritis caused by GNB species. The clinical characteristics
of all patients with culture-proven septic arthritis are
summarized in Table 1. We found that arthritis due to
Gram-positive cocci (GPC) was more likely to develop in
patients with end-stage renal disease, diabetes mellitus,
and prosthetic joints (p < 0.05), and that S. aureus was the
most prevalent GPC species.
Of the patients with arthritis due to GNB, 30 (62.5%) were
65 years of age. The knee was the most commonly
involved joint (n Z 34, 70.8%), followed by hip (n Z 8,
16.7%), ankle (n Z 4, 8.3%), elbow (n Z 1, 2.1%), and
shoulder (nZ 1, 2.1%). Only one (2.1%) patient had multiple
joint involvement (bilateral shoulders). More than half of
the infections developed in prosthetic joints, and most (24/
26) of the prosthetic joint infections developed within 6
months after joint surgery. Seven (14.6%) patients hadons and bacteriological features of culture-proven Gram-negative
(2015), http://dx.doi.org/10.1016/j.jmii.2015.08.026
Table 1 Demographic characteristics of 194 patients with septic arthritis.
Variable Patients with GPC arthritis
(n Z 146)
Patients with GNB arthritis
(n Z 48)
Age (y) 66.4  17.6 66.7  15.7
Elderly patient with age  65 y 72 (49.3) 30 (62.5)
Male 105 (71.9) 30 (62.5)
Health care-associated infection 11 (7.3) 6 (12.5)
Presentation
Single joint 143 (97.9) 47 (97.9)
Prosthetic joint* 110 (75.0) 26 (54.2)
Fever 40 (27.1) 13 (27.1)
Concomitant bacteremia 44 (30.2) 7 (14.6)
Underlying diseases
Gouty arthritis 23 (15.6) 14 (29.2)
Diabetes mellitus* 62 (42.7) 12 (25.0)
Liver cirrhosis 18 (12.5) 6 (12.3)
Cancer 11 (7.3) 5 (10.4)
Rheumatoid arthritis 2 (1.0) 3 (6.3)
End stage renal disease* 40 (27.1) 2 (4.2)
Receiving systemic steroid 6 (4.2) 5 (10.4)
Recent trauma 32 (21.9) 4 (8.3)
Laboratory examinations
C-reactive protein (mg/L, normal reference < 6 mg/L) 95.5  84.5 87.8  56.4
Synovial examination
White blood cell 77,268.4  85,675.5 65,865.7  38,704.0
Glucose (mg/dL) 168.4  85.5 153.1  81.4
Positive gram stain 18 (12.5) 7 (12.3)
Surgical treatment 67 (45.8) 26 (54.2)
Drainage 64 (43.8) 25 (52.1)
Amputation 3 (2.1) 1 (2.1)
Prosthetic surgery 18 (12.5) 11 (22.9)
In-hospital mortality 8 (5.2) 5 (10.4)
Data are presented as n (%) or mean  standard deviation.
*p < 0.05.
GNB Z Gram-negative bacteria; GPC Z Gram-positive cocci.
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(n Z 3), Escherichia coli (n Z 2), Serratia marcescens
(n Z 1), or Salmonella species (n Z 1). Polymicrobial in-
fections were diagnosed in two patients, one with Cit-
robacter koseri and Candida albicans and one with
Pseudomonas aeruginosa and Bacteroides fragilis. All of the
other patients had monomicrobial infections. Gout and
diabetes mellitus were the two most common underlying
diseases, followed by liver cirrhosis and cancer. Only seven
(12.3%) synovial specimens stained positive for GPC species.
Microbiological investigation
Of the 48 clinical GNB isolates recovered from synovial
fluid, P. aeruginosa (nZ 16, 33.3%) was the most common,
followed by E. coli (nZ 13, 28.1%), K. pneumoniae (nZ 4,
8.3%), Salmonella spp. (nZ 4, 8.3%), Enterobacter cloacae
(n Z 3, 6.3%), Stenotrophomonas maltophilia (n Z 3,
6.3%), Morganella morgannii (n Z 2, 4.2%), and one (2.1%)
each of Proteus vulgaris, S. marcescens, and C. koseri
(Table 1).
The antibiotic resistance patterns of the 48 pathogens
are shown in Table 2. Among the 29 clinical isolates ofPlease cite this article in press as: Lin W-T, et al., Clinical manifestati
bacterial arthritis, Journal of Microbiology, Immunology and InfectionEnterobacteriaceae, eight (27.6%) were resistant to cef-
triaxone, six (20.7%) were resistant to cefpirome, eight
(27.6%) were resistant to ciprofloxacin, and seven (24.1%)
were resistant to piperacillin-tazobactam. Three of the E.
coli isolates and three of the K. pneumoniae isolates were
extended-spectrum beta-lactamase producers (n Z 6,
20.7%). Among the isolates of nonfermenting GNB (NFGNB),
21.1% were resistant to ceftazidime, 21.1% were resistant
to ciprofloxacin, 26.3% were resistant to piperacillin-
tazobactam, and 15.8% were resistant to imipenem. In
addition, NFGNB isolates also showed high rates of resis-
tance to aminoglycosides (gentamicin, 36.8%; amikacin,
21.1%). There were no significant differences in resistance
rates between pathogens causing prosthetic joint infections
and those causing native joint infections.
Treatment and outcome analysis of patients with
GNB arthritis
The most commonly used antibiotic was ceftazidime
(nZ 28, 58.3%), followed by ciprofloxacin (nZ 16, 33.3%).
The average duration of parenteral and oral antibiotics was
2.3 weeks and 4.7 weeks, respectively. More than half ofons and bacteriological features of culture-proven Gram-negative
(2015), http://dx.doi.org/10.1016/j.jmii.2015.08.026
Table 2 Antibiotic resistance patterns of the 48 pathogens.




NFGNB (n Z 19)
No. of resistant bacteria
causing prosthetic joint
infections (n Z 26)
No. of resistant bacteria
causing native joint
infections (n Z 28)
Ampicillin 25 (86.2) 13 (50.0) 12 (42.9)
Amoxicillin-clavulanate 14 (48.3) 8 (30.8) 6 (21.4)
Gentamicin 9 (31.0) 7 (36.8) 9 (34.6) 7 (25.0)
Amikacin 1 (3.4) 4 (21.1) 3 (11.5) 2 (7.1)
Cefazolin 18 (62.1) 8 (30.8) 10 (35.7)
Cefuroxime 13 (44.8) 6 (23.1) 7 (25.0)
Ceftriaxone 8 (27.6) 5 (19.2) 3 (10.7)
Ceftazidime 8 (27.6) 4 (21.1) 7 (26.9) 5 (17.9)
Cefpirome 6 (20.7) 4 (21.1) 5 (19.2) 5 (17.9)
Ciprofloxacin 8 (27.6) 4 (21.1) 7 (26.9) 5 (17.9)
Piperacillin-tazobactam 7 (24.1) 5 (26.3) 8 (30.8) 4 (14.3)
Imipenem 1 (3.4) 3 (15.8) 2 (7.7) 2 (7.1)
ESBL 6 (20.7) 4 (15.4) 2 (7.1)
Data are presented as n (%).
ESBL Z extended-spectrum beta-lactamase; NFGNB Z nonfermenting gram-negative bacilli.
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tion or drainage therapy (Table 1), and all of them received
two-stage surgical procedures. In addition, one patient
required amputation and 11 (22.9%) patients required
prosthetic surgery. The overall in-hospital mortality rate
was 10.4% and all five of the patients who died had un-
derlying immunocompromising conditions. Two of the five
patients who died had infections due to extended-spectrum
beta-lactamase-producing K. pneumoniae, two had E. coli
infections, and one had P. aeruginosa infection. Analysis of
the outcomes showed that concomitant bacteremia (OR:
14.6, 95% CI: 1.9e115.2, pZ 0.011) and liver cirrhosis (OR:
20.0, 95%, CI: 2.4e169.9, p Z 0.006) were significant risk
factors for death (Table 3).
Discussion
Most of the cases of septic arthritis in this study were caused
by GPC (n Z 146, 75.3%). We also found that GPC arthritisTable 3 Comparison between patients who survived or died.
Patients who survived (n Z 43) Pati
ESBL 4 (9.3) 2 (4
Elderly 27 (62.8) 3 (6
Prosthesis 25 (58.1) 1 (2
Nosocomial infection 4 (9.3) 2 (4
Concomitant bacteremia 4 (9.3) 3 (6
Diabetes mellitus 10 (23.3) 2 (4
End-stage renal disease 1 (2.3) 1 (2
Liver cirrhosis 3 (7.0) 3 (6
Cancer 4 (9.3) 1 (2
Systemic steroid 4 (9.3) 1 (2
Surgery 24 (55.8) 2 (4
Drainage 23 (53.5) 2 (4
Data are presented as n (%) unless otherwise indicated.
CI Z confidence interval; ESBL Z extended-spectrum beta-lactamas
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disease, diabetes mellitus, or prosthetic joints. However,
there were no differences in clinical presentation or out-
comes between patients with arthritis due to GPC and those
with arthritis due to GNB. Our findings indicate that GPC are
much more prevalent pathogens than GNB, especially in
patients with specific diseases or conditions. Although only
about 25% of the cases of septic arthritis were caused by
GNB, the incidence is markedly higher than that reported
previously,7,8 indicating that GNB species should be consid-
ered possible pathogens in patients with septic arthritis, at
least in Taiwan. Pseudomonas spp. and E. coli were the most
common causative pathogens, occurring in about 60% of
patients with GNB septic arthritis. This finding is consistent
with that reported in previous studies.7e10 Nonetheless,
clinicians must keep in mind that septic arthritis can be
caused by less common GNB species, including K. pneumo-
niae, Salmonella spp., E. cloacae, S. maltophilia, M. mor-
gannii, P. vulgaris, S. marcescens, and C. koseri.ents who died (n Z 5) Odds ratio p 95% CI
0.0) 6.500 0.075 0.825e51.203
0.0) 0.889 1.000 0.134e5.902
0.0) 0.180 0.165 0.019e1.748
0.0) 6.500 0.75 0.825e51.203
0.0) 14.625 0.011 1.857e115.207
0.0) 2.200 0.587 0.321e15.066
0.0) 10.500 0.199 0.547e201.711
0.0) 20.000 0.006 2.354e169.915
0.0) 2.438 0.438 0.217e27.436
0.0) 2.438 0.438 0.217e27.436
0.0) 0.528 0.649 0.080e3.486
0.0) 0.580 0.660 0.088e3.825
e.
ons and bacteriological features of culture-proven Gram-negative
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+ MODELInitial appropriate antibiotic treatment is essential for
successful management of patients with septic arthritis;
however, it should be based on knowledge of the bacteri-
ology and antibiotic-susceptibility patterns. Previous
studies have shown that empirical treatment for septic
arthritis should include vancomycin for GPC, ceftriaxone
for Gram-negative cocci, and ceftazidime for GNB.11e13 In
our study, >25% of the Enterobacteriaceae isolates were
resistant to ceftriaxone, and >20% of NFGNB isolates were
resistant to ceftazidime. Among the Enterobacteriaceae
isolates, six were extended-spectrum beta-lactamase pro-
ducers. Overall, the rate of resistance to imipenem was
8.3%. Although in vitro activity does not represent in vivo
efficacy, a large-scale clinical study is warranted to eval-
uate the impact of antibiotics on the outcome of patients
with septic arthritis due to drug-resistant GNB. Our findings
suggest that broad-spectrum antibiotic therapy should be
empirically given to patients with septic arthritis in envi-
ronments where antibiotic-resistant GNB is prevalent.
Previous studies have shown a close association between
GNB septic arthritis and invasive urinary tract infections,
old age, intravenous drug use, compromised immunity, and
skin infections.8,12 In this study, more than half (n Z 27,
56.3%) of the patients had immunocompromising condi-
tions, such as diabetes mellitus, liver cirrhosis, cancer, or
end-stage renal disease. In addition, the majority (62.5%) of
patients in this study were of advanced age. We did not
investigate the association between septic arthritis and
urinary tract infection or intravenous drug use. Our findings
indicate that GNB should be considered possible pathogens
in immunocompromised patients and in elderly patients
with septic arthritis.
In this study, 14 (29.2%) patients had underlying gout.
Clinically, the presentations of gout and septic arthritis may
overlap, and it is difficult to differentiate them from each
other without further examination of the synovial fluid.
Therefore, physicians should perform arthrocentesis for
differential diagnosis.
The overall mortality rate in our study was 10.4%, which
is consistent with previous studies showing mortality rates
ranging from 10% to 20%.6,14,15 Moreover, we found that
death was significantly associated with concomitant
bacteremia (OR: 14.6, 95% CI: 1.9e115.2, p Z 0.011) and
liver cirrhosis (OR: 20.0, 95% CI: 2.4e169.9, p Z 0.006).
Morbidities including amputation, arthrodesis, and pros-
thetic surgery were more common in our study (>50% of
patients) than in the study by Kaandorp et al15 who re-
ported that such morbidities were present in about 33% of
patients with bacterial arthritis. The difference could be
due to differences in study design and populations studied.
In summary, these findings indicate that GNB septic
arthritis causes significant morbidity and mortality, espe-
cially in patients with liver cirrhosis and concomitant
bacteremia.
There are several limitations to this study. First, our
findings are based on an investigation of patients treated at
only one institution; therefore, the findings might not be
generalizable to other hospital populations. Second, this
study was a retrospective investigation, and bias could have
been introduced by missing data. Third, we used all-cause
mortality for the outcome analysis and did not evaluate
mortality attributable to septic arthritis.Please cite this article in press as: Lin W-T, et al., Clinical manifestati
bacterial arthritis, Journal of Microbiology, Immunology and InfectionIn conclusion, this study provides physicians with useful
epidemiological information about GNB septic arthritis. We
found that about one-fourth of the cases of septic arthritis
were caused by GNB and that resistance to commonly used
antimicrobial agents was common. Furthermore, septic
arthritis due to GNB was associated with significant
morbidity and mortality, and liver cirrhosis and concomi-
tant bacteremia were significant risk factors for death.Conflicts of interest
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